M. Vainio et al., ADENOSINE INHIBITS DNA-SYNTHESIS STIMULATED WITH TSH, INSULIN, AND PHORBOL 12-MYRISTATE 13-ACETATE IN RAT-THYROID FRTL-5 CELLS, Journal of cellular physiology, 171(3), 1997, pp. 336-342
Adenosine has been shown to modulate cell proliferation in FRTL-5 thyr
oid cells, although the mechanisms by which this interaction occurs is
still unclear. In the present study we investigated the effects of ad
enosine on the H-3-thymidine incorporation, cell cycle kinetics, and e
xpression of the transcription factor c-Fos in cells stimulated via th
ree different mitogenic pathways, i.e., by thyroid stimulating hormone
(TSH) [adenosine 3',5'-cyclic monophosphate(cAMP)], insulin (tyrosine
kinase), or phorbol 12-myristate 13-acetate (protein kinase C). Addit
ion of adenosine to cells grown in medium containing hormones and seru
m did not inhibit the incorporation of H-3-thymidine. If adenosine was
added to hormone-deprived cells together with any of the tested mitog
ens, the stimulation of the H-3-thymidine incorporation was inhibited
in a dose-dependent manner. The inhibition was significantly lower whe
n the cells were preincubated with TSH or insulin for 48 h. Flow cytom
etric studies showed that adenosine evoked an inhibition of the cells
in the G(0)/G(1) phase. Submaximal doses of adenosine (10 nM-10 mu M)
were able to induce c-Fos expression in FRTL-5 cells. However, the mit
ogen-induced expression of c-Fos was not reduced by maximal dose of ad
enosine (100 mu M). The effect of adenosine on DNA synthesis was not d
ependent on pertussis toxin-sensitive C-proteins. In addition, adenosi
ne A(1)- or A(2)-receptor antagonists did not block the effect of aden
osine. The effect of adenosine was abolished by treatment of the cells
with adenosine deaminase, suggesting that the observed effect was not
mediated by a metabolite of adenosine. The results suggest that adeno
sine is an effective blocker of mitogen-evoked DNA synthesis of FRTL-5
cells, provided that adenosine is administered simultaneously with th
e mitogen. (C) 1997 Wiley-Liss, Inc.